ZA201203915B - Fibronectin: growth factor chimeras - Google Patents

Fibronectin: growth factor chimeras

Info

Publication number
ZA201203915B
ZA201203915B ZA2012/03915A ZA201203915A ZA201203915B ZA 201203915 B ZA201203915 B ZA 201203915B ZA 2012/03915 A ZA2012/03915 A ZA 2012/03915A ZA 201203915 A ZA201203915 A ZA 201203915A ZA 201203915 B ZA201203915 B ZA 201203915B
Authority
ZA
South Africa
Prior art keywords
fibronectin
growth factor
factor chimeras
chimeras
growth
Prior art date
Application number
ZA2012/03915A
Other languages
English (en)
Inventor
Lonkhuyzen Derek Van
Zee Upton
Original Assignee
Univ Queensland Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/627,647 external-priority patent/US20100143442A1/en
Priority claimed from US12/793,386 external-priority patent/US8871709B2/en
Application filed by Univ Queensland Technology filed Critical Univ Queensland Technology
Publication of ZA201203915B publication Critical patent/ZA201203915B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
ZA2012/03915A 2009-11-30 2012-05-29 Fibronectin: growth factor chimeras ZA201203915B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/627,647 US20100143442A1 (en) 2003-02-05 2009-11-30 Growth factor complexes and modulation of cell migration and growth
US12/793,386 US8871709B2 (en) 2003-02-05 2010-06-03 Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
PCT/AU2010/001613 WO2011063477A1 (en) 2009-11-30 2010-11-30 Fibronectin: growth factor chimeras

Publications (1)

Publication Number Publication Date
ZA201203915B true ZA201203915B (en) 2018-11-28

Family

ID=44065756

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/03915A ZA201203915B (en) 2009-11-30 2012-05-29 Fibronectin: growth factor chimeras

Country Status (12)

Country Link
EP (1) EP2507261B1 (enExample)
JP (1) JP2013511960A (enExample)
KR (1) KR101930916B1 (enExample)
CN (1) CN102725308A (enExample)
AU (1) AU2010324554B2 (enExample)
BR (1) BR112012013035A8 (enExample)
CA (1) CA2781474C (enExample)
ES (1) ES2619938T3 (enExample)
NZ (1) NZ600454A (enExample)
RU (1) RU2012127364A (enExample)
WO (1) WO2011063477A1 (enExample)
ZA (1) ZA201203915B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871709B2 (en) * 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
CN103834664B (zh) * 2014-03-27 2016-05-04 吉林大学 重组表皮生长因子egf及其制备方法
CA3040467C (en) * 2016-10-14 2023-10-31 Neomatrix Therapeutics, Inc Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
WO2019010533A1 (en) * 2017-07-12 2019-01-17 Factor Therapeutics Limited TREATMENT OF OCULAR DISORDERS
CN110123732A (zh) * 2019-04-03 2019-08-16 广州市拉凯尔干细胞研究所 一种含有纤连蛋白化妆品原料制备方法
KR102440312B1 (ko) * 2020-08-28 2022-09-05 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도
CN119264240B (zh) * 2024-09-10 2025-03-25 浙江诸暨聚源生物技术有限公司 功能增强的重组纤连蛋白及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
CA1341598C (en) 1988-07-15 2009-09-29 Central Sydney Area Health Service Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex
US6090790A (en) 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
JP2866134B2 (ja) * 1990-02-05 1999-03-08 寳酒造株式会社 機能性ポリペプチド
AU649066B2 (en) 1990-07-25 1994-05-12 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP2829405B2 (ja) * 1991-10-14 1998-11-25 寳酒造株式会社 機能性ポリペプチド
US5958764A (en) 1992-04-30 1999-09-28 Baylor College Of Medicine Specific expression vectors and methods of use
AU6136694A (en) 1993-02-12 1994-08-29 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
AUPM672594A0 (en) 1994-07-08 1994-08-04 Royal Children's Hospital Research Foundation A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
DE69518437T2 (de) * 1994-11-29 2001-02-08 Takara Shuzo Co., Ltd. Verfahren zur herstellung transformierter zellen
ES2259182T3 (es) * 1995-11-13 2006-09-16 Takara Bio Inc. Metodo de introduccion de genes en celulas diana por medio de retrovirus.
JP3974941B2 (ja) 1995-11-21 2007-09-12 イェール ユニバーシティ 単分子セグメントの増幅および検出
US5752019A (en) 1995-12-22 1998-05-12 International Business Machines Corporation System and method for confirmationally-flexible molecular identification
US5835382A (en) 1996-04-26 1998-11-10 The Scripps Research Institute Small molecule mimetics of erythropoietin
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
WO1999047070A1 (en) 1998-03-18 1999-09-23 Wake Forest University Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
AUPP298498A0 (en) 1998-04-17 1998-05-07 Gropep Pty Ltd Matrix binding factor
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
WO2000055206A1 (en) 1999-03-18 2000-09-21 The Hope Heart Institute Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor
AU2003900481A0 (en) * 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
JP2008125460A (ja) * 2006-11-22 2008-06-05 Institute Of Physical & Chemical Research フィブリン結合性成長因子
US8759300B2 (en) * 2007-06-14 2014-06-24 The Research Foundation For The State University Of New York Polypeptides and methods of use

Also Published As

Publication number Publication date
CN102725308A (zh) 2012-10-10
EP2507261B1 (en) 2016-12-21
CA2781474C (en) 2019-06-18
BR112012013035A8 (pt) 2018-04-03
ES2619938T3 (es) 2017-06-27
KR101930916B1 (ko) 2018-12-19
EP2507261A1 (en) 2012-10-10
AU2010324554A1 (en) 2012-06-21
EP2507261A4 (en) 2013-04-10
NZ600454A (en) 2014-10-31
RU2012127364A (ru) 2014-01-10
WO2011063477A1 (en) 2011-06-03
KR20120114277A (ko) 2012-10-16
JP2013511960A (ja) 2013-04-11
AU2010324554B2 (en) 2014-07-31
BR112012013035A2 (pt) 2017-05-16
CA2781474A1 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
IL252193B (en) greenhouse
PL2292187T3 (pl) Endoproteza rosnąca
IL215035A0 (en) Algae biomass fractionation
ZA201204371B (en) Biofuels via hydrogenolysis-condensation
ZA201105462B (en) Crystalline insulin-conjugates
GB0905611D0 (en) Bioreactor
GB0907413D0 (en) Novel methods
IL220368A0 (en) Anaerobic beactor
GB0922659D0 (en) Factor H
ZA201203915B (en) Fibronectin: growth factor chimeras
GB0816577D0 (en) Growth factor
ZA201200628B (en) Fermentation process
AU329647S (en) Sofa
ZA201108490B (en) Fermentation
GB0907601D0 (en) Novel methods
PT2274977E (pt) Anzol
GB0906310D0 (en) Culture
GB0906306D0 (en) Culture
GB0906301D0 (en) Culture
GB0906302D0 (en) Culture
GB0906304D0 (en) Culture
GB0906305D0 (en) Culture
GB0906307D0 (en) Culture
GB0906308D0 (en) Culture
GB0906303D0 (en) Culture